Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology - PubMed (original) (raw)
Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology
Sofia Buonocore et al. Nature. 2010.
Abstract
The key role of interleukin (IL)-23 in the pathogenesis of autoimmune and chronic inflammatory disorders is supported by the identification of IL-23 receptor (IL-23R) susceptibility alleles associated with inflammatory bowel disease, psoriasis and ankylosing spondylitis. IL-23-driven inflammation has primarily been linked to the actions of T-helper type 17 (TH17) cells. Somewhat overlooked, IL-23 also has inflammatory effects on innate immune cells and can drive T-cell-independent colitis. However, the downstream cellular and molecular pathways involved in this innate intestinal inflammatory response are poorly characterized. Here we show that bacteria-driven innate colitis is associated with an increased production of IL-17 and interferon-gamma in the colon. Stimulation of colonic leukocytes with IL-23 induced the production of IL-17 and interferon-gamma exclusively by innate lymphoid cells expressing Thy1, stem cell antigen 1 (SCA-1), retinoic-acid-related orphan receptor (ROR)-gammat and IL-23R, and these cells markedly accumulated in the inflamed colon. IL-23-responsive innate intestinal cells are also a feature of T-cell-dependent models of colitis. The transcription factor ROR-gammat, which controls IL-23R expression, has a functional role, because Rag-/-Rorc-/- mice failed to develop innate colitis. Last, depletion of Thy1+ innate lymphoid cells completely abrogated acute and chronic innate colitis. These results identify a previously unrecognized IL-23-responsive innate lymphoid population that mediates intestinal immune pathology and may therefore represent a target in inflammatory bowel disease.
Figures
Figure 1
IL-23 induced IL-17 and IFN-γ are required for _H. hepaticus_-mediated innate colitis. a, Cytokine secretion following overnight culture of splenocytes or cLP cells from control or _H. hepaticus_–infected 129SvEv_Rag_−/− mice (n=6 per group). b, Cytokine secretion by cLP cells from control 129SvEv_Rag_−/− mice following overnight culture with IL-12 or IL-23 (n=6). Data represents mean ± s.e.m. Colitis scores (c), splenomegaly (d), and representative colon photomicrographs (×50) (e) from H. hepaticus infected 129SvEv_Rag_−/− mice treated with blocking α-IL-17 and/or α-IFNγ or isotype (Iso) control mAbs. Data represents two pooled experiments (n=5-12 per group). *P<0.05; **P<0.01; ***P<0.001.
Figure 2
IL-23-responsive innate lymphoid cells in inflamed colon are Thy1hiSCA-1+ RORγt+. a,b IL-17, IFN-γ and Thy1 expression in Lin− cLP cells from _H. hepaticus_–infected 129SvEv_Rag_−/− mice following overnight culture with or without IL-23 c, Phenotypic analysis of Lin−IL-17+ cLP cells from _H. hepaticus_-infected 129SvEv_Rag_−/− mice, using specific antibodies (black line) and isotype controls (grey line). d, Cytokine secretion and e, IL-23R, RORγt,AHR and Tbx21 mRNA expression, by sorted Thy1hiSCA-1+ or the remaining cLP cells (Rest) from _H. hepaticus_–infected 129SvEv_Rag_−/− mice following overnight culture with or without IL-23. Results are representative of ≥ 2 independent experiments.
Figure 3
Thy1hi innate lymphoid cells drive _H. hepaticus_-induced innate intestinal inflammation. a, Frequency of Thy1hiSCA-1+ cells (n=3-6) and b, IL-17 expression among Thy1hi cells following culture with or without IL-23 in cLP cells from control or _H. hepaticus_–infected 129SvEv_Rag_−/− mice. Data are representative of 2 independent experiments. Colitis and typhlitis scores (c), splenomegaly (d), and representative photomicrographs (×50; scale bars 200μm) (e) from H. hepaticus infected mice treated with α-Thy1 or isotype (Iso) control mAbs (n=6 per group). f, IL-17 and IFN-γ secretion by cLP cells from the mice described above, following stimulation with or without IL-23. Data represents mean ± s.e.m. (n=6). *P<0.05; ** P<0.01.
Figure 4
RORγt-expressing Thy1hi innate lymphoid cells are required for α-CD40-induced innate intestinal inflammation. Colitis scores (a), colon photomicrographs (×50) (b) weight loss (c) and cLP cytokine secretion following overnight culture (d) in α-CD40 treated C57BL/6 _Rag_−/− mice injected with or without α-Thy1 or isotype control mAb. e, RORγt mRNA expression by sorted Thy1hi SCA-1+ or the remaining cLP cells (Rest) from α-CD40 treated mice. Results are representative of 2 independent experiments. Colitis scores (f) and photomicrographs (×50) (g) from α-CD40 treated C57BL/6 _Rag_−/− or C57BL/6 _Rag_−/−_Rorc_−/− mice. (a-c) Data represent pooled results from two experiments (n=6-10 ) and (f,g) (n=11-13). (d) Data represents mean ± s.e.m. (n=5).**P<0.01; ***P<0.001.
Similar articles
- IL-23R+ innate lymphoid cells induce colitis via interleukin-22-dependent mechanism.
Eken A, Singh AK, Treuting PM, Oukka M. Eken A, et al. Mucosal Immunol. 2014 Jan;7(1):143-54. doi: 10.1038/mi.2013.33. Epub 2013 May 29. Mucosal Immunol. 2014. PMID: 23715173 Free PMC article. - Dysregulated balance of retinoid-related orphan receptor γt-dependent innate lymphoid cells is involved in the pathogenesis of chronic DSS-induced colitis.
Kimura K, Kanai T, Hayashi A, Mikami Y, Sujino T, Mizuno S, Handa T, Matsuoka K, Hisamatsu T, Sato T, Hibi T. Kimura K, et al. Biochem Biophys Res Commun. 2012 Nov 2;427(4):694-700. doi: 10.1016/j.bbrc.2012.09.091. Epub 2012 Sep 26. Biochem Biophys Res Commun. 2012. PMID: 23022186 - IL-1β mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4(+) Th17 cells.
Coccia M, Harrison OJ, Schiering C, Asquith MJ, Becher B, Powrie F, Maloy KJ. Coccia M, et al. J Exp Med. 2012 Aug 27;209(9):1595-609. doi: 10.1084/jem.20111453. Epub 2012 Aug 13. J Exp Med. 2012. PMID: 22891275 Free PMC article. - IL-23 in inflammatory bowel diseases and colon cancer.
Neurath MF. Neurath MF. Cytokine Growth Factor Rev. 2019 Feb;45:1-8. doi: 10.1016/j.cytogfr.2018.12.002. Epub 2018 Dec 12. Cytokine Growth Factor Rev. 2019. PMID: 30563755 Review. - Interleukin-23 and T helper 17-type responses in intestinal inflammation: from cytokines to T-cell plasticity.
Morrison PJ, Ballantyne SJ, Kullberg MC. Morrison PJ, et al. Immunology. 2011 Aug;133(4):397-408. doi: 10.1111/j.1365-2567.2011.03454.x. Epub 2011 Jun 2. Immunology. 2011. PMID: 21631495 Free PMC article. Review.
Cited by
- Decoding the mosaic of inflammatory bowel disease: Illuminating insights with single-cell RNA technology.
Liu L, Davidorf B, Dong P, Peng A, Song Q, He Z. Liu L, et al. Comput Struct Biotechnol J. 2024 Jul 11;23:2911-2923. doi: 10.1016/j.csbj.2024.07.011. eCollection 2024 Dec. Comput Struct Biotechnol J. 2024. PMID: 39421242 Free PMC article. Review. - Type 17 immunity: novel insights into intestinal homeostasis and autoimmune pathogenesis driven by gut-primed T cells.
Ohara D, Takeuchi Y, Hirota K. Ohara D, et al. Cell Mol Immunol. 2024 Oct 8. doi: 10.1038/s41423-024-01218-x. Online ahead of print. Cell Mol Immunol. 2024. PMID: 39379604 Review. - How underappreciated autoinflammatory (innate immunity) mechanisms dominate disparate autoimmune disorders.
Abacar K, Macleod T, Direskeneli H, McGonagle D. Abacar K, et al. Front Immunol. 2024 Sep 20;15:1439371. doi: 10.3389/fimmu.2024.1439371. eCollection 2024. Front Immunol. 2024. PMID: 39372419 Free PMC article. Review. - Human IL-22 receptor-targeted small protein antagonist suppress murine DSS-induced colitis.
Kuchař M, Sloupenská K, Rašková Kafková L, Groza Y, Škarda J, Kosztyu P, Hlavničková M, Mierzwicka JM, Osička R, Petroková H, Walimbwa SI, Bharadwaj S, Černý J, Raška M, Malý P. Kuchař M, et al. Cell Commun Signal. 2024 Oct 1;22(1):469. doi: 10.1186/s12964-024-01846-w. Cell Commun Signal. 2024. PMID: 39354587 Free PMC article. - The role of trained immunity in sepsis.
Wang W, Ma L, Liu B, Ouyang L. Wang W, et al. Front Immunol. 2024 Aug 15;15:1449986. doi: 10.3389/fimmu.2024.1449986. eCollection 2024. Front Immunol. 2024. PMID: 39221248 Free PMC article. Review.
References
- McGeachy MJ, Cua DJ. Th17 cell differentiation: the long and winding road. Immunity. 2008;28:445–453. - PubMed
- Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity. 2006;24:179–189. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous